LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.12 | 21.74 | 3436 | 6211 | 0.5531 | 0.8600 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.12 | 21.74 | 5141 | 6211 | 0.8276 | 0.9542 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.12 | 21.74 | 793 | 6211 | 0.1277 | 0.5540 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.12 | 21.74 | 6366 | 6211 | 1.0248 | 1.0060 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.09 | 21.74 | 3215 | 6201 | 0.5184 | 0.8452 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.09 | 21.74 | 5315 | 6201 | 0.8571 | 0.9625 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.09 | 21.74 | 663 | 6201 | 0.1069 | 0.5205 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.09 | 21.74 | 6509 | 6201 | 1.0496 | 1.0119 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.06 | 21.74 | 2441 | 6152 | 0.3968 | 0.7854 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.06 | 21.74 | 5423 | 6152 | 0.8815 | 0.9693 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.06 | 21.74 | 419 | 6152 | 0.0681 | 0.4380 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.06 | 21.74 | 6577 | 6152 | 1.0691 | 1.0165 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.03 | 21.74 | 2120 | 6155 | 0.3444 | 0.7547 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.03 | 21.74 | 5614 | 6155 | 0.9121 | 0.9775 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.03 | 21.74 | 318 | 6155 | 0.0517 | 0.3901 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 86.03 | 21.74 | 6598 | 6155 | 1.0719 | 1.0171 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.00 | 21.74 | 1690 | 6081 | 0.2779 | 0.7085 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.00 | 21.74 | 5787 | 6081 | 0.9516 | 0.9878 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.00 | 21.74 | 207 | 6081 | 0.0340 | 0.3195 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 88.00 | 21.74 | 6686 | 6081 | 1.0994 | 1.0235 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 89.97 | 21.74 | 1304 | 6084 | 0.2143 | 0.6548 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 89.97 | 21.74 | 5953 | 6084 | 0.9784 | 0.9946 | MN20160310_N01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 89.97 | 21.74 | 96 | 6084 | 0.0158 | 0.2005 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 89.97 | 21.74 | 6667 | 6084 | 1.0957 | 1.0226 | MN20160310_N01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 91.94 | 21.74 | 1007 | 6121 | 0.1645 | 0.6022 | MN20160310_N01 | D10 |